These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28103537)

  • 1. Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies.
    Pisal MM; Nawale LU; Patil MD; Bhansali SG; Gajbhiye JM; Sarkar D; Chavan SP; Borate HB
    Eur J Med Chem; 2017 Feb; 127():459-469. PubMed ID: 28103537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
    Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
    Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study.
    Subhedar DD; Shaikh MH; Nawale L; Sarkar D; Khedkar VM; Shingate BB
    Bioorg Med Chem Lett; 2017 Feb; 27(4):922-928. PubMed ID: 28110868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents.
    Gholap S; Tambe M; Nawale L; Sarkar D; Sangshetti J; Damale M
    Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29292534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
    Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
    Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
    ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
    Ramprasad J; Nayak N; Dalimba U
    Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
    Modi P; Patel S; Chhabria M
    Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
    Rashmi P; Nargund LV; Hazra K; Chandra JN
    Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis.
    Rode ND; Sonawane AD; Nawale L; Khedkar VM; Joshi RA; Likhite AP; Sarkar D; Joshi RR
    Chem Biol Drug Des; 2017 Dec; 90(6):1206-1214. PubMed ID: 28609019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
    Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
    Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies.
    Reddy DS; Hosamani KM; Devarajegowda HC
    Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and docking studies of some novel (R)-2-(4'-chlorophenyl)-3-(4'-nitrophenyl)-1,2,3,5-tetrahydrobenzo[4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents.
    Barot KP; Jain SV; Gupta N; Kremer L; Singh S; Takale VB; Joshi K; Ghate MD
    Eur J Med Chem; 2014 Aug; 83():245-55. PubMed ID: 24972340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
    Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
    Jadhavar PS; Dhameliya TM; Vaja MD; Kumar D; Sridevi JP; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2663-9. PubMed ID: 27095514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.